首页 | 本学科首页   官方微博 | 高级检索  
检索        

透穴针法联合退黄合剂灌肠治疗肝硬化顽固型腹水的临床研究
引用本文:白佳萌,刘光伟.透穴针法联合退黄合剂灌肠治疗肝硬化顽固型腹水的临床研究[J].针刺研究,2022(1):59-64.
作者姓名:白佳萌  刘光伟
作者单位:1.河南中医药大学第一临床医学院;2.河南中医药大学第一附属医院消化科
基金项目:河南省中医药科学研究重点专项课题(No.2018JDZX109);河南省中医药科学研究专项课题(No.2019ZYBJ04)。
摘    要:目的:观察透穴针法联合退黄合剂灌肠对肝硬化顽固型腹水患者肝功能,门静脉血流动力学,血浆一氧化氮(NO)、肠源性内毒素(ETM)及干扰素γ(IFN-γ)的影响.方法:将120例肝硬化顽固型腹水患者随机分为观察组和对照组,每组60例(观察组脱落2例,对照组脱落3例).对照组给予常规西医治疗联合退黄合剂保留灌肠,观察组在对照...

关 键 词:肝硬化顽固型腹水  透穴针法  退黄合剂

Clinical research of refractory ascites of cirrhosis treated with acupoint-penetrating needling technique of acupuncture and enema with tuihuang mixture
BAI Jia-meng,LIU Guang-wei.Clinical research of refractory ascites of cirrhosis treated with acupoint-penetrating needling technique of acupuncture and enema with tuihuang mixture[J].Acupuncture Research,2022(1):59-64.
Authors:BAI Jia-meng  LIU Guang-wei
Institution:,First Clinical Medical School of Henan University of Chinese Medicine,Department of Gastroenterology, The First Affiliated Hospital of Henan University of Chinese Medicine
Abstract:Objective To observe the effects on liver function, portal hemodynamics, plasma nitric oxide(NO), intestinal endotoxin(ETM) and interferon γ(IFN-γ) treated with acupoint-penetrating needling technique of acupuncture and enema with tuihuang mixture in the patients with refractory ascites of cirrhosis. Methods A total of 120 patients with refractory ascites of cirrhosis were divided randomly into an observation group and a control group, 60 cases in each one. In the control group, the routine western medicine treatment was applied in combination with enema with tuihuang mixture. In the observation group, on the base of the treatment as the control group, acupoint-penetrating needling technique of acupuncture was added, Zhongwan(CV12) penetrated toward Shuifen(CV9), CV9 toward Qihai(CV6), CV6 toward Guanyuan(CV4) and CV4 toward Zhongji(CV3) respectively. The duration of treatment was 60 days in both groups. The clinical therapeutic effect was analyzed in the patients of both groups. Before and after treatment, the changes in body mass, abdominal circumference, 24 h urine output/week, maximum depth of dark area of ascites, liver function indicators, portal vein hemodynamics, plasma NO, ETM and IFN-γ were observed in the patients of the two groups. Results The total effective rate was 81.03%(47/58) in the observation group, higher than 63.16%(36/57) in the control group(P<0.05). After treatment, in the self-comparison of each group, the levels of body mass, abdominal circumference, the maximum depth of the dark area of ascites, the main portal vein diameter(Dpv), maximum blood flow velocity(Vmax) and venous blood flow(Q) were all lower than those before treatment(P<0.05), 24 h urine output/week was higher than that before treatment(P<0.05), and every indicator of liver function was improved(P<0.05). After treatment, the values of body mass, abdominal circumference, the maximum depth of the dark area of ascites, Dpv, Vmax and Q in the observation group were all lower than those in the control group(P<0.05), 24 h urine output/week was higher than that in the control group(P<0.05), and the improvement in every indicator of liver function was larger than that in the control group(P<0.05). The levels of plasma NO and ETM after treatment were all lower than those before treatment in both two groups(P<0.05), and the level of IFN-γ was higher than that before treatment(P<0.05). After treatment, the levels of NO and ETM in the observation group were lower than those of the control group and the level of IFN-γ was higher than that in the control group(P<0.05). Conclusion The combined therapy of acupoint-penetrating needling technique of acupuncture and enema with tuihuang mixture effectively improves the effective rate on refractory ascites of cirrhosis, which is related to the decrease of endotoxin and the improvements of portal hemodynamics and cellular immune function.
Keywords:Refractory ascites of cirrhosis  Acupoint-penetrating needling technique of acupuncture  Tuihuang mixture
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号